News / Asia

    Patent Dispute Threatens Access to Cheap Drugs in India

    Indians suffering from HIV/AIDS attend a protest against the drugs manufacturer Novartis in New Delhi, India, January 29, 2007. Novartis is challenging a specific provision of the law that restricts the patenting of medicines to innovations only. Indians suffering from HIV/AIDS attend a protest against the drugs manufacturer Novartis in New Delhi, India, January 29, 2007. Novartis is challenging a specific provision of the law that restricts the patenting of medicines to innovations only.
    x
    Indians suffering from HIV/AIDS attend a protest against the drugs manufacturer Novartis in New Delhi, India, January 29, 2007. Novartis is challenging a specific provision of the law that restricts the patenting of medicines to innovations only.
    Indians suffering from HIV/AIDS attend a protest against the drugs manufacturer Novartis in New Delhi, India, January 29, 2007. Novartis is challenging a specific provision of the law that restricts the patenting of medicines to innovations only.
    Anjana Pasricha
    NEW DELHI — A long running legal battle in India over drug patents could impact access to affordable, lifesaving drugs to millions of people across the globe. 

    The case is being seen as a high stakes battle between drug companies supporting intellectual property rights and those who favor the production of cheap, generic drugs.   
    Dr. Suniti Solomon has treated thousands of men and women suffering from HIV at her clinic in the southern city of Chennai since she detected India’s first AIDS infection 25 years ago. Affordable copies of brand name drugs produced by India’s booming generic drug industry have helped her patients enormously.   
     
    “Earlier, when we did not have generic drugs, maybe one or two percent of my patients could afford the drugs from abroad," Solomon said. "Now, 60 to 70 percent can easily afford at least the first line drugs which keep them alive for maybe ten years or longer.”
     
    Like the patients in Chennai, these generic drugs are a lifeline for millions of people in Africa and other developing countries.
     
    Many of them are not aware of it, but a case pending before the Indian Supreme Court could have a far reaching impact on their access to these inexpensive drugs. 

    It involves a legal challenge by Swiss pharmaceutical company Novartis to India’s refusal to grant a patent for a medicine used to treat leukemia. It has been winding its way through the Indian courts for almost six years. Final arguments will be heard next month.  
     
    India denied a patent for Gleevec saying that it is not a new medicine but a salt formulation of a known drug. India does not allow companies to patent modifications of an old medicine unless its efficacy is significantly improved.
     
    Forty countries, including the United States, China and Russia, have granted a patent for Gleevec. But in India, its generic version is being produced at a fraction of the cost.
     
    Novartis says it is seeking clarity on how innovation by the drug industry will be protected in India. Ranjit Shahani, who heads the India operations of Novartis, says inadequate patent protection will discourage innovators.  
     
    “The long road to innovation research is fraught with risks and huge costs," Shahani said. "Only one out of ten thousand experimental compounds in development will reach the marketplace and the cost is between one to two billion dollars for each medicine approved. A successful molecule that makes it as a drug needs to pay for thousands of those molecules that fail.”
     
    The case has attracted international attention. The multinational drug industry sees the Indian law as a way of circumventing patent rights and wants more stringent standards.
     
    However, supporters of India’s patent law say that it prevents a practice called “evergreening,” in which drug companies get new patents by making minor changes to older ones and stave off generic competition.
     
    Leena Menghaney, a lawyer with Doctors Without Borders in New Delhi, calls it a test case.   
     
    “If Novartis wins, it can have a huge chilling effect on generic production. Once patenting standards are lowered, that means more patents are granted on drugs, that means less number of drugs generic companies will be able to manufacture. So it has implications across the board for all essential medicines, particularly for HIV,” Mengheny said.
     
    Health activists fear that a ruling in favor of Novartis may drastically reduce the global supply of inexpensive, generic drugs being used to treat people suffering from deadly diseases. They say if costs rise greatly, voluntary groups across the world will have to significantly scale down programs assisting patients who cannot afford lifesaving medicines.
     
    One such patient is a 23-year-old student in Mumbai, Siddhesh Tilekar. Since he was diagnosed with cancer about three years ago, he gets drugs from a local cancer support group.
     
    “We cannot afford that much of cost," Tilekar said. "If my family spends on my medicine, it is very difficult for us to survive.”
     
    Multinational drug companies are worried about other provisions in India’s patent law.

    Earlier this year, India allowed a domestic company to manufacture an expensive anti-cancer drug developed by Bayer Corporation using a rule under which a license can be granted if a drug is not available at a “reasonably affordable price.”  
     
    According to Ranjit Shahani at Novartis, protecting patents is critical.
     
    “The reality is without patents there will be no new drugs and without new drugs there will be no generics," he said. "So if innovation is not protected, it is the patient who will be the ultimate loser.”
     
    Lawyers say there are also worries that India’s patent laws could become a model for other developing countries, limiting the multinational drug industry’s access to these fast-growing markets.

    You May Like

    Video Somali, AU Forces Face Resurgent Al-Shabab

    Somalia’s Western backers frustrated over country’s slow progress in establishing its armed forces to bring security after 25 years of chaos

    Israel Makes Push for Gaza Strip Recovery

    After years of economic blockade and attempts to disable Hamas, Israeli leaders eventually realized that Hamas’ downfall could lead to chaos or the rise of a more radical Jihadist group

    Slump in Chinese Tourists Hitting Hong Kong Retail

    Mainland Chinese account for up to three-quarters of visitors to Hong Kong, but that number is falling, and shopping centers are struggling to 'shift gears' and maintain sales

    This forum has been closed.
    Comment Sorting
    Comments
         
    by: patent litigation from: Mexico
    July 23, 2012 4:01 AM
    Compulsory licensing is a contemporary necessity, and I'm glad to see countries from Australian to China implementing this model. I, for one, am heartened not only by the Indian Patent Office's recent decision to grant a compulsory license, but also by the further news that India now has plans to distribute some life-saving drugs for free. That -- and not gouging suffering patients at every possible opportunity -- seems to me to be the epitome of corporate responsibility.
    http://www.generalpatent.com/blog

    by: C Karen Stopford from: Connecticut
    July 21, 2012 8:38 AM
    What the pharmaceutical companies are saying is patently (no pun intended) false. Not every country lives by the American ethos of "profit at all costs." Why, believe it or not, there are some places in the world where human life has a value greater than a big credit limit. And innovation occurs in these places because people are respected, valued, allowed to explore and learn and satisfy their curiosity, and because people want to help other people. In fact, that's where most innovations come from. Not in America, of course - but elsewhere. Our system is cruel, unjust, immoral and unethical - and we will bully every other country in the world to do as we do - or else. Let 'em die! We need a profit!

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Somali, African Union Forces Face Resurgent Al-Shababi
    X
    Henry Ridgwell
    April 28, 2016 4:20 PM
    The Islamic State terror group claimed its first attack in Somalia earlier this week, though the claim has not been verified by forces on the ground. Meanwhile, al-Shabab militants have stepped up their attacks as Somalia prepares for elections later this year. Henry Ridgwell reports there are growing frustrations among Somalia’s Western backers over the country’s slow progress in forming its own armed forces to establish security after 25 years of chaos.
    Video

    Video Somali, African Union Forces Face Resurgent Al-Shabab

    The Islamic State terror group claimed its first attack in Somalia earlier this week, though the claim has not been verified by forces on the ground. Meanwhile, al-Shabab militants have stepped up their attacks as Somalia prepares for elections later this year. Henry Ridgwell reports there are growing frustrations among Somalia’s Western backers over the country’s slow progress in forming its own armed forces to establish security after 25 years of chaos.
    Video

    Video Bangladesh Targeted Killings Spark Wave of Fear

    People in Bangladesh’s capital are expressing deep concern over the brutal attacks that have killed secular blogger, and most recently a gay rights activist and an employee of the U.S. embassy. Xulhaz Mannan, an embassy protocol officer and the editor of the country’s only gay and transgender magazine Roopban; and his friend Mehboob Rabbi Tanoy, a gay rights activist, were hacked to death by five attackers in Mannan’s Dhaka home earlier this month.
    Video

    Video Documentary Tells Tale of Chernobyl Returnees

    Ukraine this week is marking the 30th anniversary of the world's worst nuclear accident, at the Chernobyl nuclear power plant. Soviet officials at first said little about the accident, but later evacuated a 2,600-square-kilometer "exclusion zone." Some people, though, came back. American directors Holly Morris and Anne Bogart created a documentary about this faithful and brave community. VOA's Tetiana Kharchenko reports from New York on "The Babushkas of Chernobyl." Carol Pearson narrates.
    Video

    Video Nigerians Feel Bite of Buhari Economic Policy

    Despite the global drop in the price of oil, Nigerian President Muhammadu Buhari has refused to allow the country's currency to devalue, leading to a shortage of foreign exchange. Chris Stein reports from Lagos businessmen and consumers are feeling the impact as the country deals with a severe fuel shortage.
    Video

    Video  Return to the Wild

    There’s a growing trend in the United States to let old or underused golf courses revert back to nature. But as Erika Celeste reports from one parcel in Grafton, Ohio, converting 39 hectares of land back to green space is a lot more complicated than just not mowing the fairway.
    Video

    Video West Urges Unity in Libya as Migrant Numbers Soar

    The Italian government says a NATO-led mission aimed at stemming the flow of migrants from Libya to Europe could be up and running by July. There are concerns that the number of migrants could soar as the route through Greece and the Balkans remains blocked. Western powers say the political chaos in Libya is being exploited by people smugglers — and they are pressuring rival groups to come together under the new unity government. VOA's Henry Ridgwell reports.
    Video

    Video Russia’s TV Rain Swims Against Tide in Sea of Kremlin Propaganda

    Russia’s media freedoms have been gradually eroded under President Vladimir Putin as his government has increased state ownership, influence, and restrictions on critical reporting. Television, where most Russians get their news, has been the main target and is now almost completely state controlled. But in the Russian capital, TV Rain stands out as an island in a sea of Kremlin propaganda.
    Video

    Video Kurdish Town Receives Refugees but Lacks Resources

    A wave of refugees is pouring into the Kurdish town of Afrin in northern Syria as a result of fighting between rebel forces and Islamic State militants. VOA’s Amina Misto went to the town and reports local authorities are finding it difficult to cope with this influx of internally displaced people. Bronwyn Benito narrates her report.
    Video

    Video Scientists Build Human Tissue on Animal Matrix

    The question has always been, if a gecko can grow back its tail, why can't we regenerate our lost body parts? Well, maybe we can, someday. Scientists are moving towards the ability to rebuild fully functioning organs, and have made significant progress replacing muscles and other tissue.
    Video

    Video Containing Chernobyl Radiation Continues 30 Years After Explosion

    April 26 marks the 30th anniversary of the Chernobyl nuclear disaster. Hundreds were killed following the explosion and it's estimated that thousands more have died from cancers caused by the radiation. Henry Ridgwell traveled to Chernobyl and reports for VOA on the continuing efforts to decommission the site -- and on the fledgling plans for a new future in the vast exclusion zone.
    Video

    Video Frustration Builds Among Refugees Trapped at Macedonian Border

    On the Greek border with Macedonia, 12,000 refugees continue to wait. Since the route to the rest of Europe was closed last month, the makeshift camp at Idomeni has seen protests and tear gas. But while those here wait, their frustration grows — as do reports of people attempting to find new ways of continuing their journey. John Owens reports from Idomeni.
    Video

    Video Researchers: Bees Help Kenyan Farmers Fend Off Elephants

    Elephant crop-raiding continues to be a major source of human-wildlife conflict in Kenya, so one elephant researcher is helping to alleviate the problem near Tsavo East National Park with beehive fences, which use elephants’ natural aversion to bees to deter them from farms. VOA’s Jill Craig visited the area ahead of this month's Giants Club Summit, which will bring together dignitaries at Mount Kenya to find solutions to combat poaching, the No. 1 threat to elephants.

    Special Report

    Adrift The Invisible African Diaspora